Perfil
Michael J.
Dawson is currently the Chief of Staff at Centinela Hospital Medical Center.
Previously, he served as the Chief Medical Officer at Leading Biosciences, Inc. and Palisade Bio, Inc. from 2021 to 2022.
He holds a doctorate degree from the University of Southern California and a graduate degree from the University of California San Diego.
Cargos activos de Michael Dawson
| Empresas | Cargo | Inicio |
|---|---|---|
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Oficial de Recursos Humanos | - |
Antiguos cargos conocidos de Michael Dawson.
| Empresas | Cargo | Fin |
|---|---|---|
| PALISADE BIO, INC. | Director Técnico/Científico/I+D | 11/10/2022 |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Director Técnico/Científico/I+D | - |
Formación de Michael Dawson.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Health Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
- Bolsa de valores
- Insiders
- Michael Dawson
















